Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM14B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RTKN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB18P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAS2R41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FASLG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP65 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL26A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HELB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930286 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALML3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR7E14P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on